France
Innobiochips presents itself as a noteworthy player in the biotechnology industry, specializing in the development of the SirYus technology. This innovative platform revolutionizes the design, manufacturing, and reading of multiplex immunoassays, offering transformative diagnostic solutions in fields like organ transplantation, blood transfusion, infectious diseases, and the microbiome. By advancing in vitro diagnostics, SirYus technology not only ensures faster and more reliable results but also expands the horizon of diagnostic possibilities.
Founded in 2008 and headquartered in France, Innobiochips is strategically positioned in the biotechnology sector and aligns with industry's strides towards advanced diagnostic solutions. Their journey received a boost with a Non Equity Assistance investment on 21 July 2008, facilitated by Eurasante, emphasizing the company's potential for growth and innovation in a rapidly evolving market.
